Advanced targeted therapies effective as first-line treatment for lung cancer
The world’s top lung cancer specialists, medical professionals and researchers are convening this week in San Francisco, Calif., for the 13th World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer. According to a series of studies presented today at the WCLC, targeted therapies, as first-line treatment, have the potential to slow cancer growth and improve patient outcomes.
More: continued here
Saturday, August 1st, 2009